Sanofi (SNY) Stock Price, Financials & Summary

Price chart

Oct 6Oct 9Oct 14Oct 19Oct 22Oct 27Oct 30Nov 4

Key dataNov 4, 2026

Open$46.85

From 52W high−10.31%

Volume1.87M

Market cap$112.48B

P/E (TTM)87.5x

P/S (TTM)2.1x

Div yield5.16%

Key dataNov 4, 2026

Open

$46.85

From 52W high

−10.31%

Volume

1.87M

Market cap

$112.48B

ValuationView details →

P/E (Fwd)

22.1x

EV/EBITDA

8.0x

P/E (TTM)

87.5x

RSI (14)

71.6

MomentumView details →

1D Return

+3.56%

YTD Return

−6.28%

SummaryUpdated Sep 1, 2026

Sanofi (NASDAQ:SNY) is a multinational pharmaceutical company founded in 1973 and headquartered in Paris, France. Originally known as Sanofi-Aventis until 2011, the company has evolved into one of the world's largest pharmaceutical companies through strategic acquisitions and organic growth. Sanofi operates as a diversified healthcare company with a focus on innovative medicines, vaccines, and consumer health products, serving patients across more than 170 countries worldwide.

Ask drillr about Sanofi →

ValuationView details →

P/E (Fwd)

22.1x

P/E (TTM)

87.5x

EV/EBITDA

8.0x

EV/Sales

2.4x

P/S (TTM)

2.1x

P/B (TTM)

1.5x

ProfitabilityView details →

Gross Margin

73.02%

Net Margin

8.09%

EBITDA Margin

30.20%

ROE (TTM)

5.72%

ROA (TTM)

3.07%

Asset Turnover

0.38x

GrowthView details →

Revenue YoY

+13.42%

EPS YoY

−87.50%

FCF YoY

+462.31%

Revenue CAGR 3Y

+4.82%

EPS CAGR 3Y

+0.10%

EBITDA YoY

+36.18%

MomentumView details →

1D Return

+3.56%

YTD Return

−6.28%

1Y Return

−7.52%

RSI (14)

71.6

vs 50D SMA

+7.63%

vs 200D SMA

+2.49%

Capital & dividendView details →

Debt/Equity

0.34x

Current Ratio

0.99x

Quick Ratio

0.23x

Div Yield

5.16%

Div Rate

$2.42

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

$2.04

EPS Surprise

30.02%

Beats (12Q)

9/12

Next Q EPS Est

$1.03

Avg Surprise (4Q)

12.61%

Rev Surprise

12.80%

Financials snapshotView financials →

Revenue (TTM)

50.98B

Net Income (TTM)

4.18B

Op. CF (TTM)

—

Next earningsFeb 4, 2027 →

Latest newsMore news →

China’s Ministry of Commerce held a roundtable in Shanghai with more than 100 multinational companies and foreign business associations attending.58m ago

RECURSION PHARMACEUTICALS, INC. reported third-quarter revenue up 258.5%, with results boosted by a $10 million milestone payment from Sanofi.23h ago

Similar companies

GSK plcGSK Bristol-Myers Squibb CompanyBMY CSPC Pharmaceutical Group Limited01093.HK 片仔癀600436.SH Pfizer Inc.PFE Novo Nordisk A/SNVO Find similar companies →

Latest newsMore news →

China’s Ministry of Commerce held a roundtable in Shanghai with more than 100 multinational companies and foreign business associations attending.58m ago RECURSION PHARMACEUTICALS, INC. reported third-quarter revenue up 258.5%, with results boosted by a $10 million milestone payment from Sanofi.23h ago